<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/tranexamic-acid-contraceptive-implant-bleeding-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Tranexamic acid did not fix breakthrough bleeding from the contraceptive implant</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/time-restricted-eating-pcos-weight-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Time-restricted eating helped women with PCOS lose weight, no more than calorie cutting</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/testosterone-diminished-ovarian-reserve-ivf-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Testosterone gel before IVF did not lift pregnancy rates in women with low ovarian reserve</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/frozen-embryo-transfer-natural-vs-programmed-cycle</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>For frozen embryo transfer, a natural cycle matched hormones, with fewer complications</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/swog-s1600-immunonutrition-radical-cystectomy</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Immune-boosting nutrition did not cut complications after bladder-cancer surgery</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/nirsevimab-rsv-effectiveness-quebec</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Nirsevimab cut infant RSV hospitalisations 89% in Quebec&apos;s first funded season</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/nirsevimab-rsv-effectiveness-ontario-quebec</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Nirsevimab linked to 78% less lab-confirmed RSV in a Canadian infant study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/matrix-ielsg43-autologous-transplant-cns-lymphoma</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Stem-cell transplant beat standard consolidation in primary CNS lymphoma trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/inactivated-rotavirus-vaccine-phase-1-china</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>An injected, inactivated rotavirus vaccine clears a first safety trial in infants</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/hsct-late-onset-metachromatic-leukodystrophy-registry</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Stem-cell transplant delayed decline in late-onset metachromatic leukodystrophy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/ensitrelvir-covid-postexposure-prophylaxis</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Oral antiviral ensitrelvir cut Covid infections in household contacts in one trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/e4512-crizotinib-adjuvant-alk-lung-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Adjuvant crizotinib did not improve survival in resected ALK-positive lung cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/daliah-interferon-hydroxyurea-myeloproliferative-neoplasms</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Interferon matched hydroxyurea for molecular response in a blood-cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/recombinant-flu-vaccine-nursing-home-outbreaks</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Recombinant flu vaccine cut nursing-home outbreaks in one season, not the next</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/melatonin-mtnr1b-glucose-tolerance</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Melatonin blunted insulin release in carriers of a common diabetes gene variant</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/lose-af-weight-loss-atrial-fibrillation</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Weight loss helped older atrial-fibrillation patients lose weight, but not their symptoms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/indocyanine-green-zyogreen-imaging-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>FDA approves Zyogreen, a ready-to-use indocyanine green for surgical imaging</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/gas-x-simethicone-propylene-glycol-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Haleon recalls Gas-X Extra Strength softgels in a Class I coolant-leak action</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/fosaprepitant-navitrux-antiemetic-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>FDA clears Navitrux, an intravenous fosaprepitant, for chemotherapy nausea</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/fenfluramine-developmental-epileptic-encephalopathy-registry</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Fenfluramine cut seizures across a range of severe epilepsies in a registry study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/explore-ckd-lorundrostat-ckd-albuminuria</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Lorundrostat lowered blood pressure and albuminuria in a small kidney-disease trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/depemokimab-asthma-meta-analysis</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Twice-yearly asthma antibody depemokimab cut flare-ups but not day-to-day symptoms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/baxter-sodium-chloride-viaflex-fiberglass-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Baxter recalls saline IV bags over fiberglass particles in a Class I action</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/bax24-baxdrostat-ambulatory-blood-pressure</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30</news:publication_date>
      <news:title>Baxdrostat lowered round-the-clock blood pressure in a resistant-hypertension trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/zosurabalpin-crab-acinetobacter-in-vitro</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A first-in-class antibiotic held its edge against resistant Acinetobacter</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/vla15-lyme-vaccine-booster-phase-2</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A Lyme vaccine&apos;s second yearly booster held up in a phase 2 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/h5n1-oseltamivir-resistant-d1-1-british-columbia</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>An oseltamivir-resistant H5N1 turned up on farms with no drug pressure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/enhance-magrolimab-azacitidine-mds</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>ENHANCE: magrolimab added toxicity but no benefit in higher-risk MDS</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/covid-2025-2026-vaccine-effectiveness-older-adults</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Updated COVID shots cut hospitalisation in over-65s, interim data show</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/acoustic-slow-wave-sleep-memory-closed-loop-crossover</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Sounds played during deep sleep improved memory in a small crossover trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/mirtazapine-methamphetamine-use-disorder-phase-3-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Mirtazapine modestly cut methamphetamine use in an Australian phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/latam-fingers-multidomain-lifestyle-cognitive-decline</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A structured lifestyle programme beat health advice for cognition in Latin America</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/ecopipam-tourette-syndrome-phase-3-randomised-withdrawal</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Ecopipam cut relapse risk in children with Tourette syndrome in a phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/traditional-food-markets-pathogen-prevalence-meta-analysis</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Pathogens turn up in one in six samples from traditional food markets, review finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/dose-sparing-ipv-infants-india-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A quarter-dose polio shot made in India matches full IPV in an infant trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/curavivax-dha-piperaquine-chloroquine-brazil</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>In the Amazon, an artemisinin combination outperforms chloroquine for vivax malaria</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/bundibugyo-ebola-seventh-province-7890-cases</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>DRC&apos;s Bundibugyo Ebola outbreak reaches a seventh province and 7,890 cases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/ruxolitinib-cream-cutaneous-lichen-planus-phase-2</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A JAK-inhibitor cream cleared skin in lichen planus, in a small early trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/morphine-dilaudid-simplist-syringe-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Fresenius Kabi recalls morphine syringes that actually contain hydromorphone</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/garetosmab-pasatru-fop-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>FDA approves garetosmab for fibrodysplasia ossificans progressiva</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/epinephrine-injection-recall-sterility</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>American Regent recalls injectable epinephrine over particulate matter and leaking vials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/apitegromab-isembyld-sma-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>FDA approves apitegromab, a myostatin inhibitor, for spinal muscular atrophy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/skyscraper-01-tiragolumab-nsclc-null</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-28</news:publication_date>
      <news:title>SKYSCRAPER-01 confirms tiragolumab added nothing in PD-L1-high lung cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/elative-elafibranor-primary-biliary-cholangitis-two-year</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-28</news:publication_date>
      <news:title>Elafibranor held its biochemical gains in PBC across three years</news:title>
    </news:news>
  </url>
</urlset>